SCHEMBL7298973

SCHEMBL7298973

[CH]NS(=O)(=O)c1c(N(C)C)ccc2ccccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ G6PD P11413 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ HCRTR1 O43613 1/20 0.36
▸ KEAP1 Q14145 2/20 0.36
▸ CHEK1 O14757 1/20 0.35
▸ NEK2 P51955 1/20 0.35
▸ LIMK1 P53667 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ MCL1 Q07820 1/20 0.35
▸ NFE2L2 Q16236 1/20 0.35
▸ HKDC1 Q2TB90 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ NSD2 O96028 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ EP300 Q09472 1/20 0.34
▸ KAT2B Q92831 1/20 0.34
▸ KAT8 Q9H7Z6 1/20 0.34
▸ CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7595952 0.84 CHEK1 (0.39) G6PDTDP1HCRTR1KEAP1CHEK1
SCHEMBL2964374 0.80 CHEK1 (0.39) TDP1KEAP1CHEK1NEK2LIMK1
SCHEMBL29827543 0.79 PAX8 (0.41) TDP1KEAP1CHEK1NEK2LIMK1
SCHEMBL5608087 0.79 SIGMAR1 (0.40) TDP1KEAP1CHEK1NEK2LIMK1
SCHEMBL2679932 0.79 CYP2D6 (0.43) G6PDTDP1KEAP1CHEK1NEK2
SCHEMBL1660887 0.79 PAX8 (0.41) TDP1KEAP1CHEK1NEK2LIMK1
SCHEMBL30502409 0.79 CYP2D6 (0.43) G6PDTDP1KEAP1CHEK1NEK2
SCHEMBL726452 0.79 CA2 (0.47) G6PDTDP1CHEK1NEK2LIMK1
SCHEMBL29773602 0.79 CA2 (0.47) G6PDTDP1CHEK1NEK2LIMK1
Hydrochloric Acid SCHEMBL28101819 0.78 EP300 (0.43) G6PDTDP1CHEK1NEK2LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5393760-A Cardiovascular disorders, antitumor agents HOFFMANN-LA ROCHE INC. (US) 1995-02-28 — — US claimed
EP-0468231-B1 Guanidins HOFFMANN LA ROCHE (CH) 1994-09-21 — — EP claimed
EP-0468231-A2 Guanidins F. HOFFMANN-LA ROCHE AG (CH) 1992-01-29 — — EP claimed
US-5763436-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1998-06-09 — — US disclosed
US-5595999-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1997-01-21 — — US disclosed
US-5583133-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1996-12-10 — — US disclosed
US-5532232-A INHIBIT THROMBIN INDUCED PLATELET AGGREGATION; FIBRINOGEN ANTICOAGULANTS IN BLOOD HOFFMANN-LA ROCHE INC. (US) 1996-07-02 — — US disclosed
US-5393760-A Cardiovascular disorders, antitumor agents HOFFMANN-LA ROCHE INC. (US) 1995-02-28 — — US disclosed
EP-0468231-B1 Guanidins HOFFMANN LA ROCHE (CH) 1994-09-21 — — EP disclosed
US-5260307-A Inhibit thrombin-induced platlet aggregation and clotting of fibrogen in plasma HOFMANN-LA ROCHE INC. (US) 1993-11-09 — — US disclosed
EP-0468231-A2 Guanidins F. HOFFMANN-LA ROCHE AG (CH) 1992-01-29 — — EP disclosed
Send feedback